CTOs on the Move

LTZ Therapeutics

www.ltztherapeutics.com

 
LTZ Therapeutics is an immunotherapy-focused biotech company to develop novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

LTZ Therapeutics raised $17M on 04/07/2022

Similar Companies

Iterion Therapeutics

Iterion Pharmaceuticals is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics.

CinCor Pharma

CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases.

Avitide

Avitide is dedicated to advancing our partners’ clinical pipelines and commercial manufacturing processes with a rapid, exclusive, and enabling affinity purification platform technology.

Marengo Therapeutics

Marengo Therapeutics is pioneering an entirely new way to activate the body`s own immune system to mount a rapid, effective, and durable response against cancer. Our unique therapeutic platform selectively boosts T cells, turbocharging potent anti-tumor activity and promoting long-term immunity to keep cancer at bay.

Neoptx

Neoptx is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.